title: Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR.
abstract: Lung cancer remains the leading cause of cancer-related mortality worldwide. The application of next-generation genomic technologies has offered a more comprehensive look at the mutational landscape across the different subtypes of non-small cell lung cancer (NSCLC). A number of recurrent mutations such as TP53, KRAS, and epidermal growth factor receptor (EGFR) have been identified in NSCLC. While targeted therapeutic successes have been demonstrated in the therapeutic targeting of EGFR and ALK, the majority of NSCLC tumors do not harbor these genomic events. This review looks at the current treatment paradigms for lung adenocarcinomas and squamous cell carcinomas, examining genomic aberrations that dictate therapy selection, as well as novel therapeutic strategies for tumors harboring mutations in KRAS, TP53, and LKB1 which, to date, have been considered "undruggable". A more thorough understanding of the molecular alterations that govern NSCLC tumorigenesis, aided by next-generation sequencing, will lead to targeted therapeutic options expected to dramatically reduce the high mortality rate observed in lung cancer.
authors.affiliation: Norton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Richer
authors.affiliation: Norton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Friel
authors.affiliation: Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
authors.forename: Vashti M
authors.initials: VM
authors.lastname: Carson
authors.affiliation: Norton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
authors.forename: Landon J
authors.initials: LJ
authors.lastname: Inge
authors.affiliation: Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Whitsett
keywords: Kirsten rat sarcoma viral oncogene homolog; epidermal growth factor receptor; non-small cell lung cancer; precision medicine; serine/threonine kinase 11; tumor protein p53